Pdt Partners, LLC Veracyte, Inc. Transaction History

Pdt Partners, LLC

$1.28 Billion
Q1 2025

A detailed history of Pdt Partners, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 69,066 shares of VCYT stock, worth $1.82 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

69,066

Previous 96,632 28.53%

Holding current value

$1.82 Million

Previous $3.83 Million 46.5%

% of portfolio

0.16%

Previous 0.38%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$29.65 - $46.14 $817,331 - $1.27 Million	-27,566 Reduced 28.53%	69,066 $2.05 Million
Q4 2024 Feb 14, 2025	BUY	$31.92 - $44.4 $850,891 - $1.18 Million	26,657 Added 38.1%	96,632 $3.83 Million
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $1.47 Million - $2.47 Million	69,975 New	69,975 $2.38 Million
Q1 2024 May 15, 2024	SELL	$21.0 - $29.1 $1.55 Million - $2.15 Million	-73,844 Reduced 84.19%	13,867 $307,000
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $216 - $315	-11 Reduced 0.01%	87,711 $2.41 Million
Q3 2023 Nov 14, 2023	BUY	$22.33 - $29.92 $245 - $329	11 Added 0.01%	87,722 $1.96 Million
Q2 2023 Aug 14, 2023	BUY	$20.96 - $26.99 $187,277 - $241,155	8,935 Added 11.34%	87,711 $2.23 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $1.62 Million - $2.2 Million	78,776 New	78,776 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $498,679 - $741,580	-14,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$32.94 - $56.62 $2.21 Million - $3.8 Million	-67,057 Reduced 82.73%	14,000 $560,000
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $2.97 Million - $5.44 Million	66,808 Added 468.86%	81,057 $4.36 Million
Q4 2020 Feb 16, 2021	BUY	$32.49 - $61.88 $203,614 - $387,801	6,267 Added 78.51%	14,249 $697,000
Q3 2020 Nov 16, 2020	BUY	$26.73 - $35.67 $213,358 - $284,717	7,982 New	7,982 $259,000
Q1 2020 May 15, 2020	SELL	$16.13 - $30.17 $167,752 - $313,768	-10,400 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$20.78 - $29.99 $993,284 - $1.43 Million	-47,800 Reduced 82.13%	10,400 $290,000
Q2 2019 Aug 14, 2019	BUY	$22.1 - $28.56 $594,490 - $768,264	26,900 Added 85.94%	58,200 $1.66 Million
Q1 2019 May 15, 2019	BUY	$12.0 - $25.76 $30,000 - $64,400	2,500 Added 8.68%	31,300 $783,000
Q4 2018 Feb 14, 2019	SELL	$9.15 - $14.85 $118,950 - $193,050	-13,000 Reduced 31.1%	28,800 $362,000
Q3 2018 Nov 14, 2018	SELL	$9.55 - $12.64 $7,210 - $9,543	-755 Reduced 1.77%	41,800 $399,000
Q2 2018 Aug 14, 2018	SELL	$5.39 - $9.66 $30,426 - $54,530	-5,645 Reduced 11.71%	42,555 $397,000
Q1 2018 May 15, 2018	SELL	$5.44 - $6.97 $2,012 - $2,578	-370 Reduced 0.76%	48,200 $268,000
Q4 2017 Feb 14, 2018	BUY	$6.05 - $9.37 $293,848 - $455,100	48,570	48,570 $317,000

Others Institutions Holding VCYT

# of Institutions

306

Shares Held

79.1M

Call Options Held

15.5K

Put Options Held

16.7K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $1.89B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account